Patents by Inventor Anna Linusson

Anna Linusson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-Piperidine Derivatives as Ccr3 Modulators
    Publication number: 20080300232
    Abstract: Compounds of formula I, processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders and to pharmaceutical compositions containing them.
    Type: Application
    Filed: March 21, 2005
    Publication date: December 4, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Kay Brickmann, Bryan J. Egner, Fabrizio Giordanetto, Tord Inghardt, Anna Linusson Jonsson, Fritiof Ponten
  • Therapeutic agents I
    Publication number: 20070185079
    Abstract: Compounds of formula(I), processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders, and pharmaceutical compositions containing them.
    Type: Application
    Filed: January 5, 2005
    Publication date: August 9, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Emma Evertsson, Tord Inghardt, Jan Lindberg, Anna Linusson, Fabrizio Giordanetto
  • Therapeutic agents II
    Publication number: 20070185119
    Abstract: Compounds of Formula (I) as well as optical isomers and racemates thereof as well as pharmaceutically acceptable salts, thereof, processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders and to pharmaceutical compositions containing them.
    Type: Application
    Filed: January 5, 2005
    Publication date: August 9, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Emma Evertsson, Tord Inghardt, Jan Lindberg, Anna Linusson